Conveying genomic recurrence risk estimates to patients with early stage breast cancer: Oncologist perspectives

OBJECTIVE: The development and increased use of genomic profiling has led to refinement of breast cancer treatment. This study sought to examine medical and surgical oncologists’ perceptions of factors related to the translation and integration of Oncotype DX((®)) into routine clinical care. METHODS...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Spellman, Elizabeth, Sulayman, Nadiyah, Eggly, Susan, Peshkin, Beth N., Isaacs, Claudine, Schwartz, Marc D., O'Neill, Suzanne C.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3757108/
https://ncbi.nlm.nih.gov/pubmed/23447452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pon.3264
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares